secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2026-08-24T12:03:23+00:00
Accession:  0001628280-26-058519
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta CEO Marotta resigns; Madaus named interim CEO; Q4 revenue guidance reaffirmed
--------------------------------------------------------------------------------

- John P. Marotta resigned as President, CEO and director effective Aug 22, 2026; no disagreement with Company.
- Dr. Martin Madaus, board member since 2024, appointed interim President and CEO; also principal executive officer.
- Madaus is Senior Operating Executive at Carlyle Group; led Millipore sale to Merck KGaA for $7.2B.
- Board reduced from 9 to 8 members; Heidrick & Struggles retained to search for permanent CEO.
- Company reaffirms Q4 FY2026 total revenue guidance; adjusted EBITDA to include ~$3M one-time consulting expense.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000162828026058519/0001628280-26-058519-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000162828026058519/azta-20260822.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-058519

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer